These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


459 related items for PubMed ID: 16238798

  • 1. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
    Iino Y, Kakizaki K, Katano H, Saigusa H, Kanegasaki S.
    Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
    [Abstract] [Full Text] [Related]

  • 2. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media.
    Iino Y, Usubuchi H, Kodama K, Kanazawa H, Takizawa K, Kanazawa T, Ohta Y.
    Otol Neurotol; 2010 Jan; 31(1):100-4. PubMed ID: 19816234
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma.
    Iino Y, Nagamine H, Kakizaki K, Komiya T, Katano H, Saruya S, Kodera K.
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):761-6. PubMed ID: 17201235
    [Abstract] [Full Text] [Related]

  • 4. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
    Xu J, Jiang F, Nayeri F, Zetterström O.
    Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
    [Abstract] [Full Text] [Related]

  • 5. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media.
    Iino Y, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, Yoshida N.
    Acta Otolaryngol; 2014 Apr; 134(4):366-72. PubMed ID: 24628335
    [Abstract] [Full Text] [Related]

  • 6. Eustachian tube function in patients with eosinophilic otitis media associated with bronchial asthma evaluated by sonotubometry.
    Iino Y, Kakizaki K, Saruya S, Katano H, Komiya T, Kodera K, Ohta K.
    Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1109-14. PubMed ID: 17043260
    [Abstract] [Full Text] [Related]

  • 7. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G, Decot V, Loiseau S, Loyens M, Chihara J, Ono N, Capron M.
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [Abstract] [Full Text] [Related]

  • 8. Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media.
    Kanazawa H, Yoshida N, Shinnabe A, Iino Y.
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):88-92. PubMed ID: 24863399
    [Abstract] [Full Text] [Related]

  • 9. Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma.
    Iino Y, Nagamine H, Yabe T, Matsutani S.
    Clin Exp Allergy; 2001 Jul; 31(7):1135-43. PubMed ID: 11468006
    [Abstract] [Full Text] [Related]

  • 10. Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophilic otitis media.
    Uchimizu H, Matsuwaki Y, Kato M, Otori N, Kojima H.
    Allergol Int; 2015 Sep; 64 Suppl():S18-23. PubMed ID: 26344075
    [Abstract] [Full Text] [Related]

  • 11. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma.
    Iino Y, Usubuchi H, Kodama K, Takizawa K, Kanazawa T, Ohta Y.
    Otol Neurotol; 2008 Oct; 29(7):949-52. PubMed ID: 18758390
    [Abstract] [Full Text] [Related]

  • 12. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.
    Shin SH, Park JY, Jeon CH, Choi JK, Lee SH.
    Laryngoscope; 2000 Aug; 110(8):1353-7. PubMed ID: 10942140
    [Abstract] [Full Text] [Related]

  • 13. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
    Park CW, Lee BH, Han HJ, Lee CH, Ahn HK.
    Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
    [Abstract] [Full Text] [Related]

  • 14. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients.
    Yao T, Kojima Y, Koyanagi A, Yokoi H, Saito T, Kawano K, Furukawa M, Kusunoki T, Ikeda K.
    Laryngoscope; 2009 Jun; 119(6):1053-9. PubMed ID: 19296494
    [Abstract] [Full Text] [Related]

  • 15. Eosinophil infiltration and activation in nasal polyposis.
    Fan GK, Wang H, Takenaka H.
    Acta Otolaryngol; 2007 May; 127(5):521-6. PubMed ID: 17453479
    [Abstract] [Full Text] [Related]

  • 16. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia.
    Jahnsen FL, Haye R, Gran E, Brandtzaeg P, Johansen FE.
    J Immunol; 1999 Aug 01; 163(3):1545-51. PubMed ID: 10415058
    [Abstract] [Full Text] [Related]

  • 17. Expression of ecalectin, a novel eosinophil chemoattractant, in nasal polyps.
    Iino Y, Miyazawa T, Kakizaki K, Saigusa H, Katano H, Shiga J, Kanegasaki S.
    Acta Otolaryngol; 2006 Jan 01; 126(1):43-50. PubMed ID: 16308254
    [Abstract] [Full Text] [Related]

  • 18. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis.
    Lucendo AJ, De Rezende L, Comas C, Caballero T, Bellón T.
    Am J Gastroenterol; 2008 Sep 01; 103(9):2184-93. PubMed ID: 18844613
    [Abstract] [Full Text] [Related]

  • 19. IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion.
    Nonaka M, Fukumoto A, Ozu C, Mokuno E, Baba S, Pawankar R, Yagi T.
    Acta Otolaryngol; 2003 Apr 01; 123(3):383-7. PubMed ID: 12737295
    [Abstract] [Full Text] [Related]

  • 20. Risk factors associated with severity of eosinophilic otitis media.
    Kanazawa H, Yoshida N, Yamamoto H, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Iino Y.
    Auris Nasus Larynx; 2014 Dec 01; 41(6):513-7. PubMed ID: 25199747
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.